Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

Experimental Neurology

Volumn 221, Issue 2, 2010, Pages 320-328

  Tsakiri, Anna ^a   Tsiantoulas, Dimitris ^b   Frederiksen, Jette ^a   Svane, Inge Marie ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c Center for Cancer Immune Therapy   (Denmark)

Author keywords

Dendritic cell; Multiple sclerosis; Optic neuritis; Simvastatin

Indexed keywords

B7 ANTIGEN; SIMVASTATIN; T6 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; IMMUNOPOTENCY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MONOCYTE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; CASE-CONTROL STUDIES; CELL COUNT; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; OPTIC NEURITIS; RECEPTORS, CCR7; SIMVASTATIN; YOUNG ADULT;

EID: 73949114426     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.11.014     Document Type: Article

References (41)

1. Adamson P., and Greenwood J. How do statins control neuroinflammation?. Inflamm. Res. 52 10 (2003) 399-403 Oct
2. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorovski T., et al. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197 6 (2003) 725-733 Mar 17
3. Allsopp C.E., Nicholls S.J., and Langhorne J. A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods 214 1-2 (1998) 175-186 May 1
4. Arden G.B., and Gucukoglu A.G. Grating test of contrast sensitivity in patients with retrobulbar neuritis. Arch. Ophthalmol. 96 9 (1978) 1626-1629
5. Brigl M., and Brenner M.B. CD1: antigen presentation and T cell function 1. Annu. Rev. Immunol. 22 (2004) 817-890
6. Bruck W., Bitsch A., Kolenda H., Bruck Y., Stiefel M., and Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42 5 (1997) 783-793 Nov
7. Chang C.C., Wright A., and Punnonen J. Monocyte-derived CD1a+and CD1a-dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J. Immunol. 165 7 (2000) 3584-3591 Oct 1
8. Dianzani U., Funaro A., DiFranco D., Garbarino G., Bragardo M., Redoglia V., et al. Interaction between endothelium and CD4+CD45RA+lymphocytes. Role of the human CD38 molecule. J. Immunol. 153 3 (1994) 952-959 Aug 1
9. El B.M., Dubucquoi S., Lefranc D., Zephir H., de S.J., Vermersch P., et al. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 96 1 (2005) 11-26 Jan 15
10. Frasca L., Fedele G., Deaglio S., Capuano C., Palazzo R., Vaisitti T., et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 107 6 (2006) 2392-2399 Mar 15
11. Frasca L., Nasso M., Spensieri F., Fedele G., Palazzo R., Malavasi F., et al. IFN-gamma arms human dendritic cells to perform multiple effector functions 3. J. Immunol. 180 3 (2008) 1471-1481 Feb 1
12. Frederiksen J.L., Petrera J., Larsson H.B., Stigsby B., and Olesen J. Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at one year follow up. Acta Neurol. Scand. 93 4 (1996) 246-252 Apr
13. Germann C.A., Baumann M.R., and Hamzavi S. Ophthalmic diagnoses in the ED: optic neuritis. Am. J. Emerg. Med. 25 7 (2007) 834-837 Sep
14. Greenwood J., Walters C.E., Pryce G., Kanuga N., Beraud E., Baker D., et al. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J. 17 8 (2003) 905-907 May
15. Greenwood J., Steinman L., and Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat. Rev. Immunol. 6 5 (2006) 358-370 May
16. Hemmer B., Nessler S., Zhou D., Kieseier B., and Hartung H.P. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat. Clin. Pract. Neurol. 2 4 (2006) 201-211 Apr
17. Huang Y.M., Xiao B.G., Ozenci V., Kouwenhoven M., Teleshova N., Fredrikson S., et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 99 1 (1999) 82-90 Sep 1
18. Huang Y.M., Kouwenhoven M., Jin Y.P., Press R., Huang W.X., and Link H. Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression. Mult. Scler. 7 2 (2001) 95-99 Apr
19. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27 12 (1997) 3135-3142 Dec
20. Klistorner A., Arvind H., Nguyen T., Garrick R., Paine M., Graham S., et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann. Neurol. 64 3 (2008) 325-331 Sep
21. Kofler S., Schlichting C., Jankl S., Nickel T., and Weis M. Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion. Atherosclerosis 197 1 (2008) 105-110 Mar
22. Krause P., Singer E., Darley P.I., Klebensberger J., Groettrup M., and Legler D.F. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J. Leukoc. Biol. 82 5 (2007) 1106-1114 Nov
23. Lanthony P. The desaturated panel D-15. Doc. Ophthalmol. 46 1 (1978) 185-189
24. Macdonald A.J., Semper A.E., Libri N.A., and Rosenberg W.M. Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells. Clin. Exp. Immunol. 148 3 (2007) 494-500 Jun
25. Miller D.H., Grossman R.I., Reingold S.C., and McFarland H.F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121 Pt. 1 (1998) 3-24 Jan
26. Ortego M., Bustos C., Hernandez-Presa M.A., Tunon J., Diaz C., Hernandez G., et al. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147 2 (1999) 253-261 Dec
27. Paraskevas K.I., Tzovaras A.A., Briana D.D., and Mikhailidis D.P. Emerging indications for statins: a pluripotent family of agents with several potential applications. Curr. Pharm. Des. 13 35 (2007) 3622-3636
28. Paul F., Waiczies S., Wuerfel J., Bellmann-Strobl J., Dorr J., Waiczies H., et al. Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS ONE 3 4 (2008) e1928
29. Pena-Cruz V., Ito S., Dascher C.C., Brenner M.B., and Sugita M. Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells 6. J. Invest. Dermatol. 121 3 (2003) 517-521 Sep
30. Peng X., Jin J., Giri S., Montes M., Sujkowski D., Tang Y., et al. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. J. Neuroimmunol. 178 1-2 (2006) 130-139 Sep
31. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58 6 (2005) 840-846 Dec
32. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 4 (1994) 1109-1118 Apr 1
33. Satthaporn S., and Eremin O. Dendritic cells (I): biological functions 4. J. R. Coll. Surg. Edinb. 46 1 (2001) 9-19 Feb
34. Sorensen T.L., Frederiksen J.L., Bronnum-Hansen H., and Petersen H.C. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 53 3 (1999) 473-478 Aug 11
35. Stuve O. Statins and the blood-brain barrier: plugging the holes. Ann. Neurol. 60 1 (2006) 1-2 Jul
36. Svane I.M., Nikolajsen K., Walter M.R., Buus S., Gad M., Claesson M.H., et al. Characterization of monocyte-derived dendritic cells maturated with IFN-alpha. Scand. J. Immunol. 63 3 (2006) 217-222 Mar
37. Weber M.S., Youssef S., Dunn S.E., Prod'homme T., Neuhaus O., Stuve O., et al. Statins in the treatment of central nervous system autoimmune disease. J. Neuroimmunol. 178 1-2 (2006) 140-148 Sep
38. Weiner H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61 10 (2004) 1613-1615 Oct
39. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7 6 (2001) 687-692 Jun
40. Wu G.F., and Laufer T.M. The role of dendritic cells in multiple sclerosis. Curr. Neurol. Neurosci. Rep. 7 3 (2007) 245-252 May
41. Yilmaz A., Reiss C., Tantawi O., Weng A., Stumpf C., Raaz D., et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 172 1 (2004) 85-93 Jan